Thyroid 1992-04-01

Dextrothyroxine in the treatment of generalized thyroid hormone resistance in a boy homozygous for a defect in the T3 receptor.

I D Schwartz, B B Bercu

Index: Thyroid 2(1) , 15-9, (1992)

Full Text: HTML

Abstract

The dextroisomer of thyroxine (D-T4) has been shown to have suppressive effects on pituitary TSH secretion in euthyroid individuals and patients with mild thyroid hormone resistance. We treated a 3-year-old boy with D-T4 who was homozygous for a T3 receptor defect, resulting in a complex clinical picture of tissue-specific hyperthyroidism and hypothyroidism. There was no evidence of significant alteration in thyroid physiology, including serum concentrations of basal and TRH stimulated TSH or echocardiographic parameters measuring systolic time interval. We conclude that D-T4 at a daily dose of 6 mg (0.65 mg/kg) was ineffective in this boy with homozygous dominant negative thyroid hormone resistance.

Related Compounds

  • Dextrothyroxine

Related Articles:

Design of mechanism-based inhibitors of transthyretin amyloidosis: studies with biphenyl ethers and new structural templates.

2007-11-15

[J. Med. Chem. 50 , 5589-99, (2007)]

Maintenance of brain thyroid hormone level during peripheral hypothyroid condition in adult rat.

2006-09-05

[Life Sci. 79(15) , 1450-5, (2006)]

Treatment of pituitary resistance to thyroid hormone (PRTH) in an 8-year-old boy.

1996-03-01

[Acta Paediatr. 85(3) , 387-90, (1996)]

A novel resistance to thyroid hormone associated with a new mutation (T329N) in the thyroid hormone receptor beta gene.

1999-02-01

[Thyroid 9(2) , 165-71, (1999)]

Effect of L-thyroxine (LT4) and D-thyroxine (DT4) on cardiac function and high-energy phosphate metabolism: a 31P NMR study.

1991-03-01

[Magn. Reson. Med. 18(1) , 237-43, (1991)]

More Articles...